Replies to post #177027 on Biotech Values

[jq1234]

I'd repeat what I said in my previous posting: PFE-AZN could fit into PFE 3 separate business model at reasonable price, not that bad a deal.

Pfizer presentation today:

http://www.pfizer.com/system/files/presentation/Investor%20Slide%20Deck%20%28April_28_FINAL%29_0.pdf